info icon

This is a non-core endpoint: only basic statistics are computed.

Induced delusional disorder

F5_INDUDEL

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 F24
  • Hospital discharge: ICD-9 2973
  • Cause of death: ICD-10 F24
  • Cause of death: ICD-9 2973

2 out of 7 registries used, show all original rules.

30

4. Check minimum number of events

None

30

5. Include endpoints

None

30

6. Filter based on genotype QC (FinnGen only)

30

Control definitions (FinnGen only)

Control exclude
F5_SCHIZO

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
F20-F29
Name in latin
Perturbatio delusionalis inducta

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 338 196 135
Only index persons 266 155 111
Unadjusted period prevalence (%)
Whole population 0.00 0.01 0.00
Only index persons 0.01 0.01 0.00
Median age at first event (years)
Whole population 49.76 55.04 41.01
Only index persons 42.98 45.65 39.26

-FinnGen-

Key figures

All Female Male
Number of individuals 30 18 12
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 32.04 27.13 39.39

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
7
0
+∞
7.59
9.1
0.0
nmol/l
1270.9
—
—
7
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
7
0
+∞
7.59
7.3
0.0
nmol/l
659.9
—
—
7
0
(3019060) Gas panel - Arterial blood
6
10
7.17
2.84
2.2
5.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
7
18
4.73
2.42
2.3
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7
18
4.73
2.42
2.0
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
8
24
4.15
2.38
2.3
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
14
67
3.04
2.20
2.6
2.7
mmol/l
8.8
8.6
0.04
14
60
(21494755) Public health laboratory ask at order entry panel
0
46
0.00
1.90
0.0
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
10
44
2.91
1.76
2.6
2.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
12
63
2.51
1.49
1.5
2.4
u/l
34.2
55.6
3.12
12
57
(3019309) Folate [Moles/volume] in Red Blood Cells
6
24
2.86
1.38
1.8
1.4
nmol/l
959.5
1137.7
—
6
17
(3017143) Hepatitis C virus Ab [Presence] in Serum
8
36
2.66
1.37
1.0
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
8
38
2.50
1.31
2.4
4.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
0
33
0.00
1.25
0.0
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
5
21
2.65
1.13
1.6
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
0
28
0.00
1.04
0.0
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
8
43
2.17
0.97
4.9
3.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
8
46
2.00
0.92
3.0
3.3
ng/l
460.8
605.4
—
8
32
(3015736) pH of Urine
13
85
1.93
0.88
3.8
2.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
9
52
2.04
0.87
23.1
6.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
26
0.00
0.83
0.0
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
20
237
0.53
0.73
31.6
11.3
%
34.8
41.7
0.67
11
199
(1761868) Lipid panel - Serum or Plasma
6
98
0.52
0.67
2.0
2.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
11
74
1.77
0.65
1.7
1.5
pmol/l
103.3
103.5
—
6
41
(3001019) Free T4 and TSH panel - Serum or Plasma
0
20
0.00
0.63
0.0
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
20
0.00
0.63
0.0
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
21
0.00
0.62
0.0
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
0
21
0.00
0.62
0.0
3.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
7
45
1.72
0.54
1.4
1.3
nmol/l
16.5
23.7
—
7
35
(42870588) Differential panel, method unspecified - Blood
10
73
1.55
0.41
9.0
5.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
24
258
0.65
0.38
16.3
9.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
11
84
1.49
0.37
5.2
2.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
18
153
1.44
0.34
4.9
3.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
7
53
1.42
0.34
9.0
5.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
5
69
0.67
0.30
4.8
2.3
—
—
—
0
0
(3044889) 12 lead EKG panel
17
146
1.38
0.28
4.2
3.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
11
0.00
0.22
0.0
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
11
0.00
0.22
0.0
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
11
0.00
0.22
0.0
2.5
—
36.5
—
0
11
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
0
11
0.00
0.22
0.0
1.3
—
395.9
—
0
11
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
11
0.00
0.22
0.0
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
0
11
0.00
0.22
0.0
5.1
—
4.8
—
0
11
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
10
0.00
0.22
0.0
1.6
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
0
10
0.00
0.22
0.0
1.1
—
3.5
—
0
10
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
0
10
0.00
0.22
0.0
2.1
—
145.8
—
0
10
(3039443) Prostate specific Ag panel - Serum or Plasma
0
10
0.00
0.22
0.0
1.8
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
10
0.00
0.22
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.22
0.0
1.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
0
10
0.00
0.22
0.0
1.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
0
10
0.00
0.22
0.0
2.0
—
100.7
—
0
10
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.3
—
7.3
—
0
6
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
7
59
1.24
0.20
1.3
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
18
195
0.81
0.14
2.8
3.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
17
184
0.82
0.12
3.1
2.7
u/l
51.2
45.0
0.21
17
178
(3001122) Ferritin [Mass/volume] in Serum or Plasma
12
107
1.20
0.10
2.4
2.9
ug/l
44.1
76.4
0.90
12
98
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
7
63
1.14
0.09
2.7
2.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
22
226
0.90
0.08
14.5
9.6
ml/min/173m2
91.1
88.9
0.21
17
177
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
23
218
1.24
0.08
5.6
3.6
mmol/l
6.2
5.8
1.63
23
202
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
9
102
0.83
0.08
3.4
4.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
12
109
1.17
0.07
5.9
5.7
umol/l
8.8
10.4
0.55
12
104
(3018010) Neutrophils/100 leukocytes in Blood
11
114
0.94
0.00
23.9
4.9
%
63.2
56.5
1.60
11
108
(3002030) Lymphocytes/100 leukocytes in Blood
11
115
0.93
0.00
18.6
5.1
%
25.4
29.8
1.43
11
109
(3006504) Eosinophils/100 leukocytes in Blood
11
111
0.99
0.00
17.2
5.0
%
1.7
3.0
1.56
11
104
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
11
110
1.00
0.00
17.5
5.4
%
7.2
8.3
0.82
11
105
(3015235) Bicarbonate [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
2.0
—
24.0
—
0
7
(3025130) Human papilloma virus identified in Specimen
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.9
—
9.2
—
0
7
(3010726) Horse dander IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
4.1
—
1.1
—
0
9
(46235355) HIV 1 and 2 tests - Meaningful Use set
7
69
1.02
0.00
1.7
2.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
0
5
0.00
0.00
0.0
2.2
—
8.3
—
0
5
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
5.0
—
39.6
—
0
7
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
23
228
1.04
0.00
3.8
3.3
mmol/l
1.6
1.3
1.24
23
211
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
5
50
1.00
0.00
1.2
2.0
mg/l
2.8
2.7
—
5
42
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
5.7
—
0.0
—
0
6
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
5.3
—
0
9
(3002523) Influenza virus A Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
6.0
—
15.2
—
0
5
(3044290) Cell count panel - Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
7
69
1.02
0.00
1.4
1.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
29.1
—
0
6
(4268621)
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
0
5
0.00
0.00
0.0
8.6
—
23.2
—
0
5
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.8
—
3.2
—
0
6
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
51.9
—
0
8
(3011985) Renin [Units/volume] in Plasma
0
6
0.00
0.00
0.0
1.0
—
22.5
—
0
6
(3021901) Oxygen saturation in Capillary blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
5.7
—
0.0
—
0
6
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
278.8
—
0
5
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
4.5
—
0.0
—
0
8
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
1.1
—
0
5
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
0
8
0.00
0.00
0.0
5.5
—
—
—
0
0
(4027681)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
35.0
—
0
5
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
5
53
0.93
0.00
3.0
2.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
5
56
0.87
0.00
2.0
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
11
110
1.00
0.00
17.0
4.9
%
0.6
0.8
0.67
11
104
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint F5_INDUDEL and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have F5_INDUDEL.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: F5_INDUDEL – Induced delusional disorder

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data